Literature DB >> 18483788

The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts.

Rupak M Rajachar1, Anh Q Truong, Cecilia M Giachelli.   

Abstract

The phosphorylated glycoprotein osteopontin (OPN) is involved in the regulation of biomineralization under normal and pathological conditions. Its actions include inhibiting apatite crystal growth and promoting the formation and function of mineral resorbing cells, including osteoclasts (OCL). The purpose of this study was to develop stable apatitic mineral surfaces and determine their influence on OCL formation and mineral resorption from bone marrow macrophages derived from OPN wild-type (OPN+/+) and OPN deficient (OPN-/-) mice. We demonstrated that these mineral coatings were stable and supported bone marrow-derived macrophage differentiation to OCL under our culture conditions. Macrophages harvested from OPN-/- mice had a greater capacity to form OCL than macrophages from OPN+/+ mice when allowed to differentiate on tissue culture plastic. In contrast, when allowed to differentiate on a mineral surface, no difference in OCL formation was observed. Interestingly, OPN+/+ OCL were more efficient at mineral dissolution than OPN-/- OCL, and this difference was observed regardless of differentiating surface. Our results suggest that mineralized substrates as well as ability to synthesize OPN both control OCL function in our model system. The exact nature of these effects may be dependent on variables related to mineral substrate presentation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483788      PMCID: PMC3997745          DOI: 10.1007/s10856-008-3455-9

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  31 in total

1.  Biomineralization. At the cutting edge.

Authors:  Steve Weiner; Lia Addadi
Journal:  Science       Date:  2002-10-11       Impact factor: 47.728

2.  Prosthetic particles modify the expression of bone-related proteins by human osteoblastic cells in vitro.

Authors:  H Zreiqat; T N Crotti; C R Howlett; M Capone; B Markovic; D R Haynes
Journal:  Biomaterials       Date:  2003-01       Impact factor: 12.479

3.  Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin.

Authors:  H Ihara; D T Denhardt; K Furuya; T Yamashita; Y Muguruma; K Tsuji; K A Hruska; K Higashio; S Enomoto; A Nifuji; S R Rittling; M Noda
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

4.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.

Authors:  G K Hunter; P V Hauschka; A R Poole; L C Rosenberg; H A Goldberg
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

5.  Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; H Tanaka; T Sasaki; T Nishihara; T Koga; T J Martin; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 6.  Osteopontin: a versatile regulator of inflammation and biomineralization.

Authors:  C M Giachelli; S Steitz
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

7.  Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase.

Authors:  M Chellaiah; K Hruska
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

8.  Polystyrene chemistry affects vitronectin activity: an explanation for cell attachment to tissue culture polystyrene but not to unmodified polystyrene.

Authors:  J G Steele; B A Dalton; G Johnson; P A Underwood
Journal:  J Biomed Mater Res       Date:  1993-07

9.  Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro.

Authors:  Cathy J Aitken; Jason M Hodge; Geoffrey C Nicholson
Journal:  J Cell Biochem       Date:  2004-11-15       Impact factor: 4.429

10.  Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro.

Authors:  S R Rittling; H N Matsumoto; M D McKee; A Nanci; X R An; K E Novick; A J Kowalski; M Noda; D T Denhardt
Journal:  J Bone Miner Res       Date:  1998-07       Impact factor: 6.741

View more
  7 in total

1.  Osteopontin regulates dentin and alveolar bone development and mineralization.

Authors:  B L Foster; M Ao; C R Salmon; M B Chavez; T N Kolli; A B Tran; E Y Chu; K R Kantovitz; M Yadav; S Narisawa; J L Millán; F H Nociti; M J Somerman
Journal:  Bone       Date:  2017-12-05       Impact factor: 4.398

2.  Cystathionine γ-lyase accelerates osteoclast differentiation: identification of a novel regulator of osteoclastogenesis by proteomic analysis.

Authors:  Takahiro Itou; Natalia Maldonado; Iwao Yamada; Claudia Goettsch; Jiro Matsumoto; Masanori Aikawa; Sasha Singh; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-12-19       Impact factor: 8.311

3.  Increased serum osteopontin is a risk factor for osteoporosis in menopausal women.

Authors:  I-C Chang; T-I Chiang; K-T Yeh; H Lee; Y-W Cheng
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

4.  RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α.

Authors:  Kate Ann Deuell; Andrea Callegari; Cecilia M Giachelli; Michael E Rosenfeld; Marta Scatena
Journal:  J Vasc Res       Date:  2012-08-30       Impact factor: 1.934

5.  Mineralization content alters osteogenic responses of bone marrow stromal cells on hydroxyapatite/polycaprolactone composite nanofiber scaffolds.

Authors:  Timothy T Ruckh; Derek A Carroll; Justin R Weaver; Ketul C Popat
Journal:  J Funct Biomater       Date:  2012-11-14

6.  Probing the surface structure of hydroxyapatite through its interaction with hydroxyl: a first-principles study.

Authors:  Xian Wang; Li Zhang; Zeyu Liu; Qun Zeng; Gang Jiang; Mingli Yang
Journal:  RSC Adv       Date:  2018-01-18       Impact factor: 4.036

7.  Properties of carbon nanotube-dispersed Sr-hydroxyapatite injectable material for bone defects.

Authors:  M G Raucci; M Alvarez-Perez; D Giugliano; S Zeppetelli; L Ambrosio
Journal:  Regen Biomater       Date:  2016-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.